🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Myelodysplastic syndromes (MDS) are a group of bone marrow failures that oc...
Status
Recruiting
Location
Shaare Zedek Medical Center
Start Date
2024-05-27
Trial ID
NCT06465160
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of liposome-en...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2016-05-02
Trial ID
NCT02642965
The purpose of this study is to determine whether stem cells collected from...
Status
Completed
Location
UPMC Hillman Cancer Center
Start Date
2015-02-11
Trial ID
NCT02167958
This is a randomized study of the European SIOP Neuroblastoma Group (SIOPEN...
Status
Recruiting
Location
Women and Children´s Hospital
Start Date
2002-02
Trial ID
NCT01704716
This study will gain information about a rare disorder called KSHV-associat...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2004-10-28
Trial ID
NCT00092222
Allogeneic hematopoietic cell transplantation (HCT) is an important therape...
Status
Unknown
Location
Instituto Nacional de Câncer José Alencar Gomes Da Silva - Inca
Start Date
2020-10-07
Trial ID
NCT04622956
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
CCOP - Mayo Clinic Scottsdale Oncology Program
Start Date
2002-09-17
Trial ID
NCT00046930
Treatments Being Tested
This is an open-label, comprehensive, iterative investigation of evaluating...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2025-03-06
Trial ID
NCT06861244
The purposes of this study are: * To examine the engraftment rate in patie...
Status
Terminated
Location
Children's Healthcare of Atlanta/Emory University
Start Date
2004-04
Trial ID
NCT00228813
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of decitabine ...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2016-11-17
Trial ID
NCT02921061